[1]
I. M. Viljoen and M. S. Pepper, “Addressing the limitations of the regulatory landscape in South Africa regarding advanced cell and gene therapies and related sectors involving human cells, tissues and organs”, S Afr Med J, vol. 115, no. 1, p. e2629, Feb. 2025, doi: 10.7196/SAMJ.2025.v115i1.2629.